Literature DB >> 10971269

Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study.

A Mehik1, P Hellström, O Lukkarinen, A Sarpola, M Järvelin.   

Abstract

OBJECTIVE: To study the lifetime occurrence of prostatitis in Finnish men and their exposure to the disease. Subjects and methods A population-based cross-sectional survey was conducted in the two most northerly provinces of Finland (Oulu and Lapland). Altogether, 2500 male residents aged 20-59 years were chosen at random to complete a questionnaire on prostatitis. The data were collected between June 1996 and October 1997. Replies were received from 1832 men, giving a response rate of 75%.
RESULTS: The overall lifetime prevalence of prostatitis was 14.2%. The risk of having or having had prostatitis increased with age, being 1.7 times greater in men aged 40-49 years than in those aged 20-39 years, and 3.1 times greater in those aged 50-59 years. The overall incidence was 37.8/10 000 person years. More than a quarter of the 261 men who had or had had prostatitis symptoms (27%) suffered from them at least once a year, while 16% suffered from persistent symptoms; 63% of the men with prostatitis had their worst symptoms during the winter (November-March). Neither education nor profession had much influence on the occurrence of prostatitis, but divorced and single men had a lower risk than married men. Most patients felt they had not received enough information about the disease at their first visit to a general practitioner.
CONCLUSIONS: The results of this survey showed that the occurrence of prostatitis symptoms in men living in northern Finland is higher than that reported in other parts of the world. This could be partly caused by the cold climate.

Entities:  

Mesh:

Year:  2000        PMID: 10971269     DOI: 10.1046/j.1464-410x.2000.00836.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  41 in total

Review 1.  Epidemiology of prostatitis: new evidence for a world-wide problem.

Authors:  John N Krieger; Donald E Riley; Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen
Journal:  World J Urol       Date:  2003-04-24       Impact factor: 4.226

2.  Towards the prevention and management of prostatic diseases in Nigeria: a framework.

Authors:  Chukwunonso Ecc Ejike
Journal:  Malays J Med Sci       Date:  2011-07

Review 3.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

Review 4.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

5.  Nutraceuticals in Prostate Disease: The Urologist's Role.

Authors:  J Curtis Nickel; Daniel Shoskes; Claus G Roehrborn; Mark Moyad
Journal:  Rev Urol       Date:  2008

6.  Prevalence of and risk factors for prostatitis in African American men: the Flint Men's Health Study.

Authors:  Lauren P Wallner; J Quentin Clemens; Aruna V Sarma
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

Review 7.  New paradigms in understanding chronic pelvic pain syndrome.

Authors:  Katy S Konkle; J Quentin Clemens
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

8.  The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey.

Authors:  Jim C Hu; Carol L Link; Mary McNaughton-Collins; Michael J Barry; John B McKinlay
Journal:  J Gen Intern Med       Date:  2007-09-01       Impact factor: 5.128

Review 9.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.